The Effects of Atypical Antipsychotic Usage Duration on Serum Adiponectin Levels and Other Metabolic Parameters | Zendy

Elif Oral | Zendy; Mustafa Güleç | Zendy; Nezahat Kurt | Zendy; Sümeyra Yılmaz | Zendy; Nazan Aydın | Zendy; İsmet Kırpınar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Effects of Atypical Antipsychotic Usage Duration on Serum Adiponectin Levels and Other Metabolic Parameters

Author(s) -

Elif Oral,

Mustafa Güleç,

Nezahat Kurt,

Sümeyra Yılmaz,

Nazan Aydın,

İsmet Kırpınar

Publication year - 2011

Publication title -

eurasian journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.337

H-Index - 13

eISSN - 1308-8742

pISSN - 1308-8734

DOI - 10.5152/eajm.2011.08

Subject(s) - adiponectin , medicine , metabolic syndrome , atypical antipsychotic , endocrinology , body mass index , adipokine , antipsychotic , triglyceride , schizophrenia (object oriented programming) , insulin resistance , waist , diabetes mellitus , cholesterol , psychiatry

Although atypical antipsychotics are well-tolerated and effective treatment options for schizophrenia, they have metabolic side effects, including weight gain and increased risk of Type II Diabetes Mellitus (DM). Adiponectin, produced exclusively in adipocytes, is the most abundant serum adipokine. Low levels of adiponectin are correlated with DM, insulin resistance and coronary heart disease. Usage of atypical antipsychotics may create a risk of metabolic syndrome. The aim of this study was to evaluate the effects of antipsychotic usage on parameters related to development of metabolic syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research